Zileuton ER 600 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F6W7C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,613
Award facts
- Contract value 100% obligated
- $14,612.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,612.97 to AmerisourceBergen Drug Corp for the supply of Zileuton ER 600 mg tablets (120-count units) on January 10, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is executed under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., functions as a major pharmaceutical distributor and critical federal medical procurement vendor specializing in supplying prescription medications, generic drugs, vaccines, and medical supplies to the Department of Defense and related healthcare systems. The company demonstrates substantial capability in fulfilling federal pharmaceutical requirements through its extensive portfolio of contract awards with the Defense Logistics Agency, delivering medications across multiple therapeutic domains including neurological treatments, pain management, diabetes care, and specialty pharmaceuticals. This award is part of DLA Troop Support's strategic pharmaceutical procurement efforts supporting military treatment facilities and veteran healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26F6W7C?
SPE2DR26F6W7C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 10, 2026.
How much is contract SPE2DR26F6W7C worth?
The government has obligated $14,613 on SPE2DR26F6W7C.
Is contract SPE2DR26F6W7C an order under another contract?
Yes. SPE2DR26F6W7C is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6W7C competed?
The extent of competition for SPE2DR26F6W7C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award